Bilal Husam Jasim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bilal Husam Jasim has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Abduljabbar I.R. Rushdi
Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, P.O. Box 14022, Iraq
1 shared publication- Adawiya J. Haider
Applied Sciences Department/Laser science and Technology branch, University of Technology, Baghdad, Iraq
1 shared publication - Ahmed Mutanabbi Abdula
Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq
1 shared publication - Ali Abdullah Issa
Department of Applied Sciences, University of Technology, Baghdad, Iraq
1 shared publication Bassam Shaker Mahmood
Biotechnology Branch, Departments of Applied Sciences, University of Technology‐Iraq, Baghdad, Iraq
1 shared publication- Doaa Saied El-Sayed
Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt
1 shared publication
Latest Publications
- Open Access
- 29 March 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Biotechnology
- Vol. 30 (1) , 26-33
Thrombolytic activity and antibacterial activity optimize staphylokinase enzyme production from Staphylococcus aureus
Staphylokinase is a virulence factor produced by Staphylococcus aureus that enhances its ability to degrade proteins, contributing to tissue damage and increased bacterial invasiveness. This investigation studied staphylokinase production by S. aureus isolates obtained from wound and burn patients. Optimal conditions for enhancing staphylokinase production in Sato’s component were determined. These conditions included a carbon source (glucose), a nitrogen source (yeast extract), an inoculum size of 1%, an incubation temperature of 37 °C, and a pH of 7. Optimization of the medium components resulted in a significant increase in staphylokinase production (26.4 U/mL), representing a 2.23‐fold rise compared to production in the unoptimized Sato’s component. The crude staphylokinase enzyme exhibited thrombolytic activity against human blood clots, achieving 42% clot lysis. However, the crude enzyme showed no antibacterial activity against the tested bacteria (Streptomyces and Escherichia coli). This study represents the first report of optimized media for enhancing staphylokinase production from S. aureus. The research is significant because it establishes a method for improving the production of highly active staphylokinase from S. aureus, which has potential applications as a thrombolytic agent.
- 29 March 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Biotechnology
- Vol. 30 (1) , 26-33
Open AccessThrombolytic activity and antibacterial activity optimize staphylokinase enzyme production from Staphylococcus aureus
Staphylokinase is a virulence factor produced by Staphylococcus aureus that enhances its ability to degrade proteins, contributing to tissue damage and increased bacterial invasiveness. This investigation studied staphylokinase production by S. aureus isolates obtained from wound and burn patients. Optimal conditions for enhancing staphylokinase production in Sato’s component were determined. These conditions included a carbon source (glucose), a nitrogen source (yeast extract), an inoculum size of 1%, an incubation temperature of 37 °C, and a pH of 7. Optimization of the medium components resulted in a significant increase in staphylokinase production (26.4 U/mL), representing a 2.23‐fold rise compared to production in the unoptimized Sato’s component. The crude staphylokinase enzyme exhibited thrombolytic activity against human blood clots, achieving 42% clot lysis. However, the crude enzyme showed no antibacterial activity against the tested bacteria (Streptomyces and Escherichia coli). This study represents the first report of optimized media for enhancing staphylokinase production from S. aureus. The research is significant because it establishes a method for improving the production of highly active staphylokinase from S. aureus, which has potential applications as a thrombolytic agent.
- 30 September 2024
- Published by IJSSHMR Publication in International Journal of Health & Medical Research
- Vol. 03 (09)
Dissecting Molecular Pathways and Intricate Mechanisms Underpinning Antibiotic Resistance in Gram-Negative Bacteria: An Exhaustive and Integrative Review
Concern for antibiotic resistance in Gram negative bacteria is fast becoming a global issue due to the reduction of effectiveness of current drugs. This review deconstructs the material in a logical, categorized manner, examining the biochemistry of antibiotic resistance mechanisms such as efflux pumps, enzymatic degradation, genetic changes, and the regulation of those changes. Close associated gene transfer, especially the plasmids-mediated resistance, and how biofilms contribute to the survival of bacteria under antibiotic pressure. Present methods of detection and diagnosis are also described with emphasis on the importance of identifying a resistant strain quickly and accurately. Last, we discuss directions for ongoing and future progress in tackling antibiotic resistance, such as new treatments and public health directions. Based on these observations, it is the hope of this review to contribute to the existing literature and initiatives geared towards reversing the escalating problem of antibiotic resistance.
- 30 September 2024
- Published by IJSSHMR Publication in International Journal of Health & Medical Research
- Vol. 03 (09)
Dissecting Molecular Pathways and Intricate Mechanisms Underpinning Antibiotic Resistance in Gram-Negative Bacteria: An Exhaustive and Integrative Review
Concern for antibiotic resistance in Gram negative bacteria is fast becoming a global issue due to the reduction of effectiveness of current drugs. This review deconstructs the material in a logical, categorized manner, examining the biochemistry of antibiotic resistance mechanisms such as efflux pumps, enzymatic degradation, genetic changes, and the regulation of those changes. Close associated gene transfer, especially the plasmids-mediated resistance, and how biofilms contribute to the survival of bacteria under antibiotic pressure. Present methods of detection and diagnosis are also described with emphasis on the importance of identifying a resistant strain quickly and accurately. Last, we discuss directions for ongoing and future progress in tackling antibiotic resistance, such as new treatments and public health directions. Based on these observations, it is the hope of this review to contribute to the existing literature and initiatives geared towards reversing the escalating problem of antibiotic resistance.
- Open Access
- 3 June 2024
- Published by University of Technology, Iraq - DIGITAL COMMONS in Journal of Applied Sciences and Nanotechnology
- Vol. 4 (2) , 22-38
Bioinformatics Analysis of BMP15 Gene and Bone Morphological Protein-15 Sequence
This study characterized the physicochemical properties and predicted the structure, function, and protein-protein interactions of bone morphogenetic protein 15 (BMP15) using bioinformatics tools. BMP15 was found to have a molecular weight of 45055.01 Daltons, sequence length of 392 amino acids, and an extinction coefficient of 55390 at 280 nm with a basic isoelectric point. Secondary structure analysis revealed BMP15 consists mostly of random coil (63.78%), followed by alpha helix (20.66%) and extended strand (15.56%) as well as beta turns. Amino acids with high coil structure like glycine and alanine, which are hydrophobic and flexible, represented the highest concentrations. Transmembrane helix prediction identified four helices located from inside to outside and three from outside to inside. SWISS-MODEL generated four protein structure models corresponding to sequences (Q6PX77.1. A, 5vqf.2. A, 5ntu.1. A, and 5hly.1. A) with sequence identities of (75.38%, 20.83%, 20.77% and 20.33%) respectively. Results correlate BMP15 with oocyte maturation and granulosa cell activation in follicular development. This comprehensive bioinformatics analysis of BMP15 properties, structure, and interactions provides a framework for further study of genetically inherited infertility, drug design, and new protein analysis.
- 3 June 2024
- Published by University of Technology, Iraq - DIGITAL COMMONS in Journal of Applied Sciences and Nanotechnology
- Vol. 4 (2) , 22-38
Open AccessBioinformatics Analysis of BMP15 Gene and Bone Morphological Protein-15 Sequence
This study characterized the physicochemical properties and predicted the structure, function, and protein-protein interactions of bone morphogenetic protein 15 (BMP15) using bioinformatics tools. BMP15 was found to have a molecular weight of 45055.01 Daltons, sequence length of 392 amino acids, and an extinction coefficient of 55390 at 280 nm with a basic isoelectric point. Secondary structure analysis revealed BMP15 consists mostly of random coil (63.78%), followed by alpha helix (20.66%) and extended strand (15.56%) as well as beta turns. Amino acids with high coil structure like glycine and alanine, which are hydrophobic and flexible, represented the highest concentrations. Transmembrane helix prediction identified four helices located from inside to outside and three from outside to inside. SWISS-MODEL generated four protein structure models corresponding to sequences (Q6PX77.1. A, 5vqf.2. A, 5ntu.1. A, and 5hly.1. A) with sequence identities of (75.38%, 20.83%, 20.77% and 20.33%) respectively. Results correlate BMP15 with oocyte maturation and granulosa cell activation in follicular development. This comprehensive bioinformatics analysis of BMP15 properties, structure, and interactions provides a framework for further study of genetically inherited infertility, drug design, and new protein analysis.
- 31 October 2021
- Vol. 76 (4) , 809-820
Isolation, Extraction, Purification, and Characterization of Fibrinolytic Enzyme from Pseudomonas aeruginosa and Estimation of the Molecular Weight of the Enzyme
Pseudomonas aeruginosa was isolated from injuries of patients' wounds and burns, and to ensure that the isolate was belonging to P. aeruginosa, several tests were performed, such as staining techniques, a biochemical test, morphological test, Vitek 2 system, and sensitivity test. The results of the gram stain test showed rod pink gram-negative bacteria, demonstrating that the isolate belonged to P. aeruginosa. Growth optimization of bacterial was performed by assessing different combinations of pH and temperatures. It is revealed that the best conditions for increasing the number of bacteria were achieved at 37°C with the bacterial number of 5.53×108 and pH 6 with the bacterial number of 5.87×108. Fibrinolytic enzyme is an agent that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases have attracted worldwide attention for their elevation morbidity and mortality. Fibrinolytic enzyme was extracted by centrifugation at 10000 × g at 4°C for 10 min, the supernatant was kept and the pellet having bacterial cells was discarded. Purification of the fibrinolytic enzyme was achieved using salt precipitation, ion exchange, and gel filtration chromatographic techniques. The results showed that the gel filtration chromatography had optimal specific activity and purification fold at 562.6 U/ml, and the final specific activity of the purified enzyme increased 4.1 times. The molecular weight of the fibrinolytic enzyme was determined at26 kDa by gel filtration chromatography. The purified fibrinolytic enzyme had optimum activity atpH 7 and40°C.The pH stability for the enzyme activity was found in pH 6-7 and the range of 10-40°C.
- 31 October 2021
- Vol. 76 (4) , 809-820
Isolation, Extraction, Purification, and Characterization of Fibrinolytic Enzyme from Pseudomonas aeruginosa and Estimation of the Molecular Weight of the Enzyme
Pseudomonas aeruginosa was isolated from injuries of patients' wounds and burns, and to ensure that the isolate was belonging to P. aeruginosa, several tests were performed, such as staining techniques, a biochemical test, morphological test, Vitek 2 system, and sensitivity test. The results of the gram stain test showed rod pink gram-negative bacteria, demonstrating that the isolate belonged to P. aeruginosa. Growth optimization of bacterial was performed by assessing different combinations of pH and temperatures. It is revealed that the best conditions for increasing the number of bacteria were achieved at 37°C with the bacterial number of 5.53×108 and pH 6 with the bacterial number of 5.87×108. Fibrinolytic enzyme is an agent that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases have attracted worldwide attention for their elevation morbidity and mortality. Fibrinolytic enzyme was extracted by centrifugation at 10000 × g at 4°C for 10 min, the supernatant was kept and the pellet having bacterial cells was discarded. Purification of the fibrinolytic enzyme was achieved using salt precipitation, ion exchange, and gel filtration chromatographic techniques. The results showed that the gel filtration chromatography had optimal specific activity and purification fold at 562.6 U/ml, and the final specific activity of the purified enzyme increased 4.1 times. The molecular weight of the fibrinolytic enzyme was determined at26 kDa by gel filtration chromatography. The purified fibrinolytic enzyme had optimum activity atpH 7 and40°C.The pH stability for the enzyme activity was found in pH 6-7 and the range of 10-40°C.
- Open Access
- 1 July 2021
- Published by University of Technology, Iraq - DIGITAL COMMONS in Journal of Applied Sciences and Nanotechnology
- Vol. 1 (2) , 58-65
Enhanced Production of Fibrinolytic Enzyme from Pseudomonas aeruginosa by Optimization Media Components
Fibrinolytic enzyme is factor that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases attracted worldwide attention for their elevation morbidity and mortality. Expensive cost and fatally undesired side effects associated with the available fibrinolytic agents to treat these diseases stimulated the researchers to investigate potentially better agents for curative applications. In the current investigation, fibrinolytic enzyme production from Pseudomonas aeruginosa isolated from injuries of wounds and burns patients. Parameters for the promoted production of the enzyme under minimal production media were optimized. It comprised carbon source (glucose), Nitrogen source (Yeast extract), Fibrinogen concentration (0.5 %), inoculum size (1 %), temperature (37°C), and PH (7). Enhanced fibrinolytic enzyme activity (136.2 IU/ml) was obtained after optimization Medium Components compared with that obtained with the minimal medium (60.2 IU/ml) which is 2.2 times higher than the same under non optimized production conditions. Media optimization researches for enhancement of fibrinolytic enzyme production from Pseudomonas aeruginosa in Iraq has not been performed so far. This may be the first study to optimization media for the production of fibrinolytic enzyme from Pseudomonas aeruginosa. The importance of this study lies in the enhancing the production of the fibrinolytic enzyme with high activity using these bacteria.
- 1 July 2021
- Published by University of Technology, Iraq - DIGITAL COMMONS in Journal of Applied Sciences and Nanotechnology
- Vol. 1 (2) , 58-65
Open AccessEnhanced Production of Fibrinolytic Enzyme from Pseudomonas aeruginosa by Optimization Media Components
Fibrinolytic enzyme is factor that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases attracted worldwide attention for their elevation morbidity and mortality. Expensive cost and fatally undesired side effects associated with the available fibrinolytic agents to treat these diseases stimulated the researchers to investigate potentially better agents for curative applications. In the current investigation, fibrinolytic enzyme production from Pseudomonas aeruginosa isolated from injuries of wounds and burns patients. Parameters for the promoted production of the enzyme under minimal production media were optimized. It comprised carbon source (glucose), Nitrogen source (Yeast extract), Fibrinogen concentration (0.5 %), inoculum size (1 %), temperature (37°C), and PH (7). Enhanced fibrinolytic enzyme activity (136.2 IU/ml) was obtained after optimization Medium Components compared with that obtained with the minimal medium (60.2 IU/ml) which is 2.2 times higher than the same under non optimized production conditions. Media optimization researches for enhancement of fibrinolytic enzyme production from Pseudomonas aeruginosa in Iraq has not been performed so far. This may be the first study to optimization media for the production of fibrinolytic enzyme from Pseudomonas aeruginosa. The importance of this study lies in the enhancing the production of the fibrinolytic enzyme with high activity using these bacteria.